Beranda › Karsinoma Epitel Ovarium › Texas
Uji klinis Karsinoma Epitel Ovarium di Texas
12 studi untuk Karsinoma Epitel Ovarium mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Texas Oncology - Austin Central /ID# 275046, Austin
- Texas Oncology - Fort Worth Cancer Center /ID# 275043, Fort Worth
- Houston Methodist Hospital /ID# 274568, Houston
- dan 3 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 29 Sep 2026 · NCT06890338Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Dallas
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05867251ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UT Southwestern Medical Center, Dallas
- DHR Health Advance Care Center, Edinburg
- The Center for Cancer and Blood Disorders, Forth Worth
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, San Antonio
- Research Site, Tyler
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 21 Jul 2026 · NCT07218809[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- University of Texas Southwestern Medical Center, Dallas
Menerima pesertaFase 1/2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT07432633CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06756035A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0103, Houston
Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 7 Apr 2026 · NCT04516447A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06395519CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- SCRI - Texas Oncology, Fort Worth
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 23 Des 2025 · NCT06690775A Study of NX-1607 in Adults With Advanced Malignancies
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT05107674Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT04429542BP1001-A in Patients With Advanced or Recurrent Solid Tumors
- Mary Crowley Cancer Research, Dallas
- The University of Texas M.D. Anderson Cancer Center, Houston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mar 2025 · NCT04196257Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.